James E. Flynn

Holdings History for Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV)

Symbol: INDV on Nasdaq
Investment type: Equity / Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares")
Latest Disclosed Shares Owned: 4,614,498 shares
Security Ownership %: 3.7%

Deerfield Mgmt, L.P. ownership in Indivior Pharmaceuticals, Inc. Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV)

13 Nov 2025 - Deerfield Mgmt, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,614,498 shares of Indivior Pharmaceuticals, Inc. Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV). This represents 3.7% ownership of the company. In their previous filing dated 13 May 2025, James E. Flynn had reported owning 10,567,160 shares, indicating a decrease of +56%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Deerfield Mgmt, L.P.	3.7%	-60%	$111,255,547	4,614,498	-5,952,662	-56%	$24.11	13G/A	10 Nov 2025	13 Nov 2025, 16:27
Deerfield Mgmt, L.P.	8.5%	+19%	$122,262,041	10,567,160	+1,684,000	+19%	$11.57	13G/A	31 Mar 2025	13 May 2025, 20:50
Deerfield Mgmt, L.P.	7.2%		$102,778,161	8,883,160			$11.57	13G/A	31 Dec 2024	13 Feb 2025, 09:39